PDF herunterladen
Open Access
CC BY 4.0 · Indian J Med Paediatr Oncol 2025; 46(05): 468-474
DOI: 10.1055/s-0045-1805024
Original Article

Carotid Artery Stenosis in Head and Neck Cancer Patients Treated with Radiotherapy

Autoren

  • Ramesh Banu

    1   Department of Oncology, Valavadi Narayanasamy Cancer Centre, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, Tamil Nadu, India

  • Divya Surendran

    1   Department of Oncology, Valavadi Narayanasamy Cancer Centre, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, Tamil Nadu, India

  • Murugaiyan Nagarajan

    1   Department of Oncology, Valavadi Narayanasamy Cancer Centre, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, Tamil Nadu, India

  • Janarthanan Maniyarasu 

    1   Department of Oncology, Valavadi Narayanasamy Cancer Centre, G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, Tamil Nadu, India

Funding None.
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Introduction

Radiotherapy (RT) is a crucial treatment modality for 80% of head and neck cancer (HNC) patients, often combined with surgery or chemotherapy, leading to a significant reduction in cancer-related mortality. However, as cancer survival rates increase, therapy-related complications also increase, impacting both mortality and morbidity. One such late complication is radiation-induced carotid artery stenosis (CAS), a condition associated with an increased risk of cerebrovascular events. Radiation-induced CAS is rarely studied, especially in the Indian population. Despite its potential severity, there is no standardized screening or management protocol for radiation-induced CAS in HNC patients.

Objectives

This study aims to assess the prevalence, risk factors, complications, management, and outcomes of CAS in HNC patients who received RT, with or without chemotherapy and surgery at our institution.

Materials and Methods

This is a retrospective observational study of newly diagnosed primary HNC patients who received RT between January 2012 and December 2021. Patients with metastatic HNC and those treated elsewhere were excluded. Data on demographics, tumor characteristics, treatment, and imaging for vascular stenosis were collected. Statistical analysis was performed using R version 4.4.1, with categorical variables analyzed using the chi-square or Fisher's exact test and continuous variables using the Mann–Whitney's U test. Significance was set at p-value </= 0.05.

Results

Of 949 patients, 34 (3.6%) developed CAS. Preradiation vascular stenosis was rare (0.1%). Among the 34 patients categorized by time since treatment, CAS developed in 47.1% of patients after 5 years, 32.4% within 2 to 5 years, and 5.9% within 1 year. CAS severity included near-total occlusion in 23.5%, ≥70% stenosis in 20.6%, and neurological deficits in 8.8%. The median age was 62 years, and the majority were male (85.3%). Common risk factors were hypertension (29.4%), diabetes (20.6%), tobacco use (82.4%), and alcohol consumption (41.2%). Tumors of oral cavity and hypopharynx were more common. Most CAS patients (76.5%) received radical chemoradiation. Only 23.3% of CAS patients received anticoagulation therapy, with 14.3% undergoing mechanical thrombectomy.

Conclusion

This study highlights the prevalence of radiation-induced CAS in HNC patients, especially in the Indian population, and identifies associated risk factors. Hence, standardized screening and management protocols for CAS are crucial for improving long-term outcomes in HNC survivors.

Keywords

carotid artery stenosis - head and neck cancer - radiotherapy - cerebrovascular events

Patient Consent

The patient consent was waived by the Institutional Ethics Committee.


Authors' Contribution

M.N. conceptualized the study and he is the guarantor. R.B. designed the study, defined the intellectual content, and edited the manuscript. R.B. and D.S. performed the literature search and prepared the manuscript. D.S. helped in data acquisition. J.M. performed the data analysis and statistical analysis. R.B. and M.N. reviewed the manuscript.




Publikationsverlauf

Artikel online veröffentlicht:
03. März 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India